Assertio Holdings (ASRT) Gains from Investment Securities (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Gains from Investment Securities came in at $189000.0 in Q1 2026, up 70.27% year-on-year from $111000.0 in Q1 2025, and down 81.51% quarter-over-quarter from $1.0 million in Q4 2025.
Assertio Holdings (ASRT) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Gains from Investment Securities across 7 years of filings, most recently posting $189000.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $189000.0, up 70.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $267000.0 (down 43.43% YoY), and the FY2025 annual result was $189000.0, down 46.0% from the prior year.
- Gains from Investment Securities came in at $189000.0 for Q1 2026 at Assertio Holdings, down from $1.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5.5 million in Q3 2023 to a low of -$3.7 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is $81000.0 (2022), against an average of $395941.2.
- Peak annual rise in Gains from Investment Securities reached 19453.57% in 2023, while the deepest fall reached 2954.2% in 2023.
- Assertio Holdings' Gains from Investment Securities stood at $131000.0 in 2022, then slumped by 2954.2% to -$3.7 million in 2023, then jumped by 72.24% to -$1.0 million in 2024, then jumped by 198.46% to $1.0 million in 2025, then plunged by 81.51% to $189000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $189000.0 (Q1 2026), $1.0 million (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -948,000.00 |
| Jun 30, 2025 | -948,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | -1.04 Mn |
| Dec 31, 2024 | -1.04 Mn |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | -11,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | -3.74 Mn |
| Dec 31, 2023 | -3.74 Mn |